382 Lebrikizumab provides clinically meaningful improvements in atopic dermatitis in patients previously treated with dupilumab.
Saved in:
| Title: | 382 Lebrikizumab provides clinically meaningful improvements in atopic dermatitis in patients previously treated with dupilumab. |
|---|---|
| Authors: | Gold, Linda Stein, Gutermuth, Jan, Adam, David N, Flohr, Carsten, Weidinger, Stephan, Atwater, Amber Reck, Pierce, Evangeline, Yang, Fan Emily, Chen, Sherry, Pau-Charles, Ignasi, Beck, Lisa A |
| Source: | The British journal of dermatology 2023 Supplement; Vol. 188. |
| Journal Info: | Publisher: Oxford University Press / USA ISSN: 0007-0963 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: EPTOC165110927 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 382 Lebrikizumab provides clinically meaningful improvements in atopic dermatitis in patients previously treated with dupilumab. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gold%2C+Linda+Stein%22">Gold, Linda Stein</searchLink><br /><searchLink fieldCode="AU" term="%22Gutermuth%2C+Jan%22">Gutermuth, Jan</searchLink><br /><searchLink fieldCode="AU" term="%22Adam%2C+David N%22">Adam, David N</searchLink><br /><searchLink fieldCode="AU" term="%22Flohr%2C+Carsten%22">Flohr, Carsten</searchLink><br /><searchLink fieldCode="AU" term="%22Weidinger%2C+Stephan%22">Weidinger, Stephan</searchLink><br /><searchLink fieldCode="AU" term="%22Atwater%2C+Amber+Reck%22">Atwater, Amber Reck</searchLink><br /><searchLink fieldCode="AU" term="%22Pierce%2C+Evangeline%22">Pierce, Evangeline</searchLink><br /><searchLink fieldCode="AU" term="%22Yang%2C+Fan+Emily%22">Yang, Fan Emily</searchLink><br /><searchLink fieldCode="AU" term="%22Chen%2C+Sherry%22">Chen, Sherry</searchLink><br /><searchLink fieldCode="AU" term="%22Pau-Charles%2C+Ignasi%22">Pau-Charles, Ignasi</searchLink><br /><searchLink fieldCode="AU" term="%22Beck%2C+Lisa+A%22">Beck, Lisa A</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220004041%22">The British journal of dermatology</searchLink> 2023 Supplement; Vol. 188. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press+%2F+USA%22">Oxford University Press / USA </searchLink><i>ISSN: </i>0007-0963 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=EPTOC165110927 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/bjd/ljad162.010 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1 Titles: – TitleFull: 382 Lebrikizumab provides clinically meaningful improvements in atopic dermatitis in patients previously treated with dupilumab. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gold, Linda Stein – PersonEntity: Name: NameFull: Gutermuth, Jan – PersonEntity: Name: NameFull: Adam, David N – PersonEntity: Name: NameFull: Flohr, Carsten – PersonEntity: Name: NameFull: Weidinger, Stephan – PersonEntity: Name: NameFull: Atwater, Amber Reck – PersonEntity: Name: NameFull: Pierce, Evangeline – PersonEntity: Name: NameFull: Yang, Fan Emily – PersonEntity: Name: NameFull: Chen, Sherry – PersonEntity: Name: NameFull: Pau-Charles, Ignasi – PersonEntity: Name: NameFull: Beck, Lisa A IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 06 Text: 2023 Supplement Type: published Y: 2023 Identifiers: – Type: issn-print Value: 1365-2133 Numbering: – Type: volume Value: 188 Titles: – TitleFull: The British journal of dermatology Type: main |
| ResultId | 1 |
